Analysis of Epidemiological, Clinical, and Laboratory Characteristics of Patients Diagnosed with Brucellosis: A Comprehensive Study
PDF
Cite
Share
Request
Original Article
P: 163-170
September 2024

Analysis of Epidemiological, Clinical, and Laboratory Characteristics of Patients Diagnosed with Brucellosis: A Comprehensive Study

Namik Kemal Med J 2024;12(3):163-170
1. Ağrı Training and Research Hospital Clinic of Infectious Diseases and Clinical Microbiology, Ağrı, Turkey
No information available.
No information available
Received Date: 20.04.2024
Accepted Date: 13.05.2024
Online Date: 20.09.2024
Publish Date: 20.09.2024
PDF
Cite
Share
Request

ABSTRACT

Aim

Brucellosis, an endemic zoonotic disease within our nation, exhibits a notably high prevalence in the Southeastern, Eastern, and Central Anatolia regions. This study aims to assess the epidemiological, clinical, and laboratory characteristics, along with the complications, among both outpatient and inpatient cases diagnosed with brucellosis in Ağrı province.

Materials and Methods

This retrospective study analyzed 121 patients under the care of the Clinic of Infectious Diseases and Clinical Microbiology at Ağrı Training and Research Hospital between January 2022 and March 2024. Diagnosis of brucellosiswas established based on clinical manifestations indicative of the disease, standard tube agglutination test titers of >=1/160, and/or isolation of Brucella spp./Brucella melitensis from blood cultures. Patients were categorized into acute, subacute, chronic (newly diagnosed), and relapsed groups based on their clinical presentations. Epidemiological, clinical, and laboratory parameters were evaluated across these patient groups.

Results: Among the 121 patients analyzed, 73 (60.3%) were female and 48 (39.7%) were male, with a mean age of 40.69 (±14.3) years. Of these patients, 87 (72%) were newly diagnosed, while 34 (28%) had experienced a relapse. Newly diagnosed patients exhibited notably higher rates of blood culture positivity and focal involvement compared to relapsed individuals (p=0.000, p=0.049, respectively). Elevated levels of C-reactive protein (CRP), sedimentation rate, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were observed among patients with organ involvement in comparison to those without organ involvement (p=0.001, p=0.022, p=0.013, p=0.035, respectively).

Conclusion: In regions where brucellosis is endemic, it should be considered among the primary differential diagnoses in patients presenting with fever. Biochemical markers such as CRP, sedimentation rate, ALT, and AST should be taken into consideration for assessing organ involvement in patients diagnosed with brucellosis. Combatting the disease requires a multidisciplinary approach, and healthcare professionals along with the local population should be educated about the disease and preventive measures.

Keywords:
Brucellosis, epidemiologia, focal involvement, fever

INTRODUCTION

Brucellosis is a widespread zoonotic disease transmitted through the consumption of unpasteurized dairy products obtained from infected animals (such as cattle, sheep, goats, camels, and pigs), or through contact with the tissues or secretions of these animals1. Rare cases of transmission have been reported via blood transfusion, tissue transplantation, nosocomial infection, and sexual contact2, 3.

Brucellosis poses a significant threat to both human and animal health and imposes a substantial burden on national economies. The prevalence of brucellosis prevalence is closely associated with local livestock activities, with higher rates observed in rural areas known for intensive animal husbandry, particularly in regions such as Southeastern Anatolia, Eastern Anatolia, and Central Anatolia in Turkey. Individuals most commonly affected by the disease include those engaged in livestock farming, veterinarians, and laboratory workers4.

The causative agent of brucellosis, Brucella spp., is a small, non-motile, facultative aerobic, intracellular bacterium that appears as Gram-negative coccobacilli in Gram staining. Among humans, Brucella melitensis is the most frequently encountered species5.

The disease typically presents with symptoms such as fever, night sweats, and muscle and joint pain. Additionally, weight loss, headache, dizziness, loss of appetite, back pain, abdominal pain, and depression may also be present6.

The incubation period of brucellosis is approximately 2-4 weeks. Based on the duration of symptoms, the disease is classified as acute if symptoms persist for the first 8 weeks, subacute if they last between 8 and 52 weeks, and chronic if symptoms persist for more than 52 weeks7. Recurrence of the disease within the first 6-12 months after treatment is classified as relapse8.

Brucellosis can involve multiple tissues and organs. The most common manifestations include osteoarticular involvement, encompassing peripheral arthritis, sacroiliitis, and spondylodiscitis9. Additionally, it may affect the genitourinary system, central nervous system, cardiovascular system, ocular system, and skin10, 11.

Definitive diagnosis of brucellosis is established by isolating the causative agent from blood or other sterile body fluids through culture, or by observing a fourfold or greater increase in Brucella antibody titers between the acute and convalescent phases. A diagnosis may also be presumed if the standard tube agglutination (STA) test yields a titer of 1/160 or higher after the onset of symptoms12.

Combination therapies form the cornerstone of brucellosis treatment. Nevertheless, despite treatment, relapse, chronicity, and organ involvement may occur, and there is no optimal recommendation for treatment regimen and duration in certain patient groups13.

Brucellosis encompasses a wide range of clinical manifestations, from non-specific symptoms to severe organ involvement, mimicking many other diseases. This variability can lead to delays in diagnosis and misdiagnosis14. Being the most common zoonotic disease worldwide, brucellosis continues to be of significance due to its impact on animal and human morbidity, reduction in animal productivity, and considerable economic burden, especially in endemic countries. Therefore, besides diagnosis and treatment, preventive measures to prevent disease transmission are equally important15.

MATERIALS AND METHODS

This retrospective study analyzed 121 patients who were either seen as outpatients or admitted to the Clinic of Infectious Diseases and Clinical Microbiology at Ağrı Training and Research Hospital between January 2022 and March 2024. Patients aged 18 years and above were included in the study.

The diagnosis of brucellosis was established in patients presenting with clinical manifestations suggestive of the disease, along with a STA test titer of ≥1/160 and/or isolation of Brucella spp./Brucella melitensis from blood cultures. Patient demographics, including age, gender, presence of comorbidities, occupational exposure to livestock, initial symptoms, physical examination findings, previous diagnosis of brucellosis, routine laboratory results, rose bengal and STA test results, blood culture results, hemogram, and biochemical data, were recorded.

Medical records pertaining to clinical follow-ups were scrutinized for evidence of systemic involvement, relapse, and development of complications. Patients with symptoms lasting less than 8 weeks were categorized as acute, those lasting between 8 and 52 weeks as subacute, and those lasting more than 52 weeks as chronic brucellosis cases. Within one year after the completion of treatment, patients exhibiting recurrent symptoms supported by physical examination and laboratory findings were classified as relapsed cases.

Diagnosis of brucellosis relied on either serological or culture positivity in conjunction with clinical findings. Serological test positivity was defined as an STA test titer ≥1/160 using specific antiserum (Ankara Public Health Laboratory, Turkey) or a ≥4-fold increase in STA test titer repeated 2-3 weeks apart. Detection of Brucella spp. and Brucella melitensis was performed using VITEK2 Compact (BioMérieux, France) and VITEK MS (BioMérieux, France) devices.

Statistical Analysis

Descriptive statistics, including mean or median values for continuous variables and count (n) and percentage (%) values for categorical variables, were provided. The normality of continuous variables was assessed using the Shapiro-Wilk test. For normally distributed variables, independent samples t-test was utilized for between-group comparisons, while the Mann-Whitney U test was employed for non-normally distributed variables. The chi-square test was applied for comparisons between categorical variables. Statistical analyses were conducted using SPSS version 26 for Windows. Results were considered significant at p<0.05 level.

The study was conducted after obtaining the necessary permissions from Ağrı İbrahim Çeçen University Scientific Research Ethics Committee (decision no: E-95531838-050.99-98272, date: 29.03.2024).

RESULTS

Of the cases, 73 (60.3%) were female and 48 (39.7%) were male, with a mean age of 40.69 (±14.3) years. Evaluation based on the place of residence revealed that 73 (60.3%) resided in rural areas, with 79 (65.3%) engaged in livestock farming, 104 (86%) consuming raw milk and dairy products, 3 (2.5%) exposed to laboratory hazards, and 4 (3.3%) with unidentified exposure. The most commonly observed comorbidities among patients were hypertension in 11 (9.1%) cases, coronary artery disease in 7 (5.8%) cases, and hyperlipidemia in 7 (5.8%) cases. Upon examining the demographic data of patients, no statistically significant differences were found between newly diagnosed and relapsed patients in terms of mean age, gender, comorbidities, place of residence, and exposure. The epidemiological data of patients are presented in Table 1.

The distribution of patients diagnosed with brucellosis by place of residence revealed the following proportions: city center 48 (39.7%), Diyadin 30 (24.8%), Taşlıçay 11 (9.1%), Hamur 9 (7.4%), Doğubayazıt 6 (5%), Patnos 6 (5%), Eleşkirt 6 (5%), and Tutak 5 (4.1%). The distribution of patients’ places of residence throughout the province is depicted in Figure 1.

When patients were evaluated based on their clinical status at the time of diagnosis, 73 (60.3%) were diagnosed with acute brucellosis, 8 (6.6%) with subacute brucellosis, 34 (28%) with recurrent brucellosis, and 6 (5%) with chronic brucellosis. Assessment of presenting symptoms revealed that the predominant symptoms were joint pain in 113 (93.4%) cases, night sweats in 96 (79.3%), fatigue in 96 (79.3%), fever in 82 (67.8%), lower back pain in 80 (66.1%), and loss of appetite in 72 (59.5%). Fever was significantly more prevalent in patients with newly diagnosed brucellosis, while headache was more pronounced in relapsing cases. The presenting symptoms of patients are provided in Table 2.

Significant differences were observed in terms of blood culture positivity between newly diagnosed and relapse patients (p=0.000). All positive blood cultures were detected in newly diagnosed patients. Furthermore, a significant difference was found in terms of organ involvement between newly diagnosed and relapse patients (p=0.049-0.059), with a higher incidence of organ involvement observed in newly diagnosed cases. Focal involvement was present in 29 patients (24% of all cases), with the most common manifestations being sacroiliitis in 12 cases (41.3%), spondylodiscitis in 7 cases (24.1%), and peripheral arthritis in 9 cases (31%). Blood cultures were obtained from 84 patients (69.4%), with Brucella melitensis or Brucella spp. isolated in 24 cases. The results of blood cultures and organ involvement are presented in Table 3.

Out of the 84 patients from whom blood cultures were obtained, Brucella spp. or Brucella melitensis growth was observed in 24 cases. It was noted that blood culture positivity was mostly prevalent during the autumn season. The distribution of blood culture positivity according to months is presented in Figure 2.

Notably, when evaluating laboratory results, C-reactive protein (CRP), sedimentation rate, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were found to be significantly higher in complicated cases, with p values of 0.001, 0.002, 0.013, and 0.035, respectively. The laboratory values of patients with and without complications are presented in Table 4.

DISCUSSION

Brucellosis continues to be endemic in areas where economic resources are limited, sanitation measures are lacking, and veterinary services are insufficient. Globally, it persists as an endemic disease in regions such as the Middle East, the Mediterranean, and Central and South America16. In Turkey, it is most commonly observed in rural areas where livestock farming is prevalent, particularly in the Southeastern Anatolia, Eastern Anatolia, and Central Anatolia regions4. In our study, we evaluated patients diagnosed with brucellosis residing in Ağrı province, and it was observed that the majority of patients lived in districts. This observation is consistent with the tendency for livestock farming activities to occur in rural areas. The higher number of diagnosed patients in Diyadin district may indicate the intense livestock farming and insufficient veterinary services in the area. Despite being the largest districts in the city, the lower number of diagnosed patients residing in Doğubayazıt and Patnos suggests that brucellosis diagnosis and treatment may be conducted in district hospitals within these regions.

In our study, 73 (60.3%) of the cases were female, and 48 (39.7%) were male, with a mean age of 40.69 (±14.3) years. In a study conducted by Turkoglu-Yilmaz and Arslan17, a retrospective evaluation of brucellosis patients over a 5-year period was conducted, revealing that 170 (72%) of 236 patients were male. In a meta-analysis comprising 57 studies examining the clinical manifestations of human brucellosis, it was found that 55% of the patients were male across all participant groups18. The higher number of female patients in our study, contrary to the literature, can be attributed to the smaller sample size.

In a study conducted by Almuneef et al.19, consumption of unpasteurized raw milk was reported as the source of brucellosis in 75% of cases, while 45% were attributed to livestock handling. In our study, when analyzed in terms of transmission routes, it was found that the disease was most commonly transmitted through the consumption of raw milk and dairy products, accounting for 86% of cases. Secondly, 65.9% of cases were associated with occupational livestock handling. This suggests that even if local residents do not engage in livestock farming themselves, they obtain raw milk and dairy products and use them without pasteurization.

In a study conducted by Kuruoglu et al.20, significantly elevated fever was observed in patients diagnosed with brucellosis across acute, subacute, chronic, and relapse patient groups. Fever was found in 79.2% of patients diagnosed with acute brucellosis. In a retrospective study by Buzgan et al.21, encompassing the last 10 years and evaluating 1028 brucellosis patients, acute, subacute, and chronic brucellosis patients comprising the newly diagnosed group accounted for 96.8% of all patients, while relapse patients constituted 3.2% of the total. The most common symptoms observed in these patients were arthralgia (73.7%) and fever (72.2%). In our study, the number of newly diagnosed brucellosis patients was 87 (72%), while the number of relapse brucellosis cases was 34 (28%). The most common symptom observed was arthralgia in 113 patients (93.4%), followed by night sweats in 96 patients (79.3%), fatigue in 96 patients (79.3%), and fever in 82 patients (67.8%). Regarding laboratory findings, elevated levels of CRP sedimentation, and anemia were prominent. However, in our study, while elevated CRP and sedimentation levels were observed in the group with focal involvement, elevated ALT and AST levels were also detected. Anemia was rarely observed. The absence of anemia may be attributed to the high altitude of the city, which predisposes individuals to polycythemia.

In a study conducted by Özdem et al.22 from Turkey, which included 189 patients, a comparison was made between bacteremic and non-bacteremic brucellosis cases. It was found that organ involvement was significantly higher in the group with positive blood cultures. However, in our study, no significant relationship was found between culture positivity and organ involvement (p=0.391). This may be attributed to the small number of patients in our study.

Large and small ruminants are most reproductively active during the spring season, coinciding with the production of fresh cheese during this period23, 24. In our study, it was observed that the positivity of blood cultures in patients was lowest in the spring months and highest in the summer and autumn months. The most common exposure factor identified in our study was the consumption of fresh cheese. The higher number of blood culture isolates in the autumn and winter months may be explained by the incubation period of brucellosis.

In our study, CRP, sedimentation rate, ALT, and AST levels were found to be significantly higher in patients with complicated disease who had organ involvement compared to non-complicated patients. Elevated CRP and sedimentation levels in patients with organ involvement may be considered as indicators of inflammation. The elevation of ALT and AST levels can be explained by brucellosis being a disease that affects the reticuloendothelial system, with the liver being a part of this system.

In conclusion, brucellosis is a zoonotic disease with significant public health implications, mimicking various illnesses, and often leading to suboptimal diagnosis and treatment management, thereby increasing the economic burden on countries. It can cause morbidity in both animals and humans. Understanding the epidemiological data of countries and regions, maintaining veterinary services, increasing knowledge among healthcare workers and local populations about the disease are crucial in combating brucellosis. This necessitates interdisciplinary collaboration.

Study Limitations

The limited number of included patients and the inability to obtain blood cultures from every patient due to technical reasons are the primary limitations of this study.

CONCLUSION

Brucellosis continues to be of global significance, necessitating further research on the epidemiological data of countries and regions. In regions where brucellosis is endemic, it should be considered as one of the primary differential diagnoses in the presence of fever. Biochemical markers such as CRP, sedimentation rate, ALT, and AST should be considered for organ involvement in patients diagnosed with brucellosis. Combatting the disease requires a multidisciplinary approach, and healthcare professionals along with the local population should be educated about the disease and preventive measures.

References

1
Corbel MJ. Brucellosis in Humans and Animals. World Health Organization; 2006. Accessed March 20, 2024.
2
Poulou A, Markou F, Xipolitos I, Skandalakis PN. A rare case of Brucella melitensis infection in an obstetrician during the delivery of a transplacentally infected infant. J Infect. 2006;53:39-41.
3
Mesner O, Riesenberg K, Biliar N, Borstein E, Bouhnik L, Peled N, et al. The many faces of human-to-human transmission of brucellosis: congenital infection and outbreak of nosocomial disease related to an unrecognized clinical case. Clin Infect Dis. 2007;45:135-40.
4
Zoonotic Diseases In-Service Training Module (2011).https://www.halksagligiokulu.org/Kitap/Detay/zoonotik-hastaliklar-hizmetici-egitim
5
Bakri FG, AlQadiri HM, Adwan MH. The Highest Cited Papers in Brucellosis: Identification Using Two Databases and Review of the Papers’ Major Findings. BioMed Res Int. 2018;2018:9291326.
6
Young EJ. Brucellosis: current epidemiology, diagnosis, and management. Curr Clin Top Infect Dis. 1995;15:115-28.
7
Yumruk Z. Brucella species. In: Willke Topçu A, Söyletir G, Doğanay M. Eds.Infectious diseases and microbiologie. Ankara: Nobel Medical Bookstores. 2017:1956-61
8
Ariza J, Corredoira J, Pallares R, Viladrich PF, Rufi G, Pujol M, et al. Characteristics of and risk factors for relapse of brucellosis in humans. Clin Infect Dis. 1995;20:1241-9.
9
Bosilkovski M, Krteva L, Caparoska S, Dimzova M. Osteoarticular involvement in brucellosis: study of 196 cases in the Republic of Macedonia. Croat Med J. 2004;45:727-33.
10
Rolando I, Olarte L, Vilchez G, Lluncor M, Otero L, Paris M, et al. Ocular manifestations associated with brucellosis: a 26-year experience in Peru. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008;46:1338-45.
11
Colmenero JD, Reguera JM, Martos F, Sánchez-De-Mora D, Delgado M, Causse M, et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine Baltimore. 1996;75:195-211.
12
Godfroid J, Cloeckaert A, Liautard JP, Kohler S, Fretin D, Walravens K, et al. From the discovery of the Malta fever’s agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res. 2005;36:313-26.
13
Kaya S. Brucellosis and difficulties in treatment. Turkish Journal of Infection. 2006;20:227–30.
14
Ulu-Kilic A, Metan G, Alp E. Clinical presentations and diagnosis of brucellosis. Recent Pat Antiinfect Drug Discov. 2013;8:34-41.
15
Mantur BG, Amarnath SK, Shinde RS. Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol. 2007;25:188-202.
16
Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 2006;6:91-9.
17
Turkoglu-Yilmaz E, Arslan Z. Retrospective Evaluation of Patients with Brucellozis: five years of Experience. Klimik Journal. 2023;36:177-82.
18
Dean AS, Crump L, Greter H, Hattendorf J, Schelling E, Zinsstag J. Clinical manifestations of human brucellosis: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2012;6:e1929.
19
Almuneef MA, Memish ZA, Balkhy HH, Alotaibi B, Algoda S, Abbas M, et al. Importance of screening household members of acute brucellosis cases in endemic areas. Epidemiol Infect. 2004;132:533-40.
20
Kuruoglu T, Sensoy L, Atilla A, Temocin F, Gur D, Tanyel E. Evaluation of risk factors for the development of bacteremia and complications in patients with brucellosis: Is it possible to predict the clinical course? J Infect Dev Ctries. 2023;17:1277-84.
21
Buzgan T, Karahocagil MK, Irmak H, Baran AI, Karsen H, Evirgen O, et al. Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature. Int J Infect Dis. 2010;14:469-78.
22
Özdem S, Tanır G, Öz FN, Yalçınkaya R, Cinni RG, Savaş Şen Z, et al. Bacteremic and Nonbacteremic Brucellosis in Children in Turkey. J Trop Pediatr. 2022;68:fmab114.
23
Chemineau P, Pelletier J, Guérin Y, Colas G, Ravault JP, Touré G, et al. Photoperiodic and melatonin treatments for the control of seasonal reproduction in sheep and goats. Reprod Nutr Dev. 1988;28:409-22.
24
Dacheux JL, Pisselet C, Blanc MR, Hochereau-de-Reviers MT, Courot M. Seasonal variations in rete testis fluid secretion and sperm production in different breeds of ram. J Reprod Fertil. 1981;61:363-71.